OpenBilldrug price receipt

NADAC week of 2026-10-14

MESALAMINE DR 400 MG CAPSULE

For 30 capsules

Pharmacies pay

$80.97 filed

30 × $2.69898 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$60.30 filed

30 × $2.00989 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

0.74× estimated

Medicare paid 26% less than pharmacies pay.

Part D averages every strength and form sold under “Mesalamine Dr” / “Mesalamine” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$98.12 estimated

$80.97 + $12.15 (15%) + $5.00 fee per fill = $98.12

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

MESALAMINE DR 400 MG CAPSULE is how the CMS NADAC file names this product. The FDA NDC Directory lists it as mesalamine.

FDA gives its dosage form as capsule, delayed release and its route as oral.

Its labelers, the companies named on the label, are Teva Pharmaceuticals USA, Inc. and American Health Packaging.

FDA’s Established Pharmacologic Class for it is Aminosalicylate.

The NADAC file of 2026-10-14 prices it under 3 NDCs (National Drug Codes); the FDA directory lists 2 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $80.97 for 30 capsules (30 × $2.69898 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

All 3 NDCs

Other strengths, forms and brands

10 other products in the NADAC file share the FDA nonproprietary name mesalamine with MESALAMINE DR 400 MG CAPSULE.

ProductPharmacies pay per unitMedicare per unit
CANASA 1,000 MG SUPPOSITORY
brand · suppository
$37.10967 per EA filed
eff. 2026-09-23
$36.05608 per EA filed
Part D 2024 average
LIALDA DR 1.2 GM TABLET
brand · tablet, delayed release
$8.94652 per EA filed
eff. 2026-09-23
We don’t know yet
MESALAMINE 1,000 MG SUPP
generic · suppository
$1.28382 per EA filed
eff. 2026-09-23
We don’t know yet
MESALAMINE 4 GM/60 ML ENEMA
generic · suspension / enema
$0.09843 to $0.17585 per ML filed
eff. 2026-09-23
We don’t know yet
MESALAMINE 4 GM/60 ML KIT
generic · kit
$134.90444 per EA filed
eff. 2026-09-23
We don’t know yet
MESALAMINE 800 MG DR TABLET
generic · tablet, delayed release
$4.02045 per EA filed
eff. 2026-09-23
$2.00989 per EA filed
Part D 2024 average
MESALAMINE DR 1.2 GM TABLET
generic · tablet, delayed release
$0.7809 per EA filed
eff. 2026-09-23
$2.00989 per EA filed
Part D 2024 average
MESALAMINE DR 400 MG CAPSULE this page
generic · capsule, delayed release
$2.69898 per EA filed
eff. 2026-09-23
$2.00989 per EA filed
Part D 2024 average
MESALAMINE ER 0.375 GRAM CAP
generic · capsule, extended release
$0.47798 per EA filed
eff. 2026-09-23
$1.37992 per EA filed
Part D 2024 average
PENTASA 250 MG CAPSULE
brand · capsule
$2.90086 per EA filed
eff. 2026-09-23
$5.03307 per EA filed
Part D 2024 average
PENTASA 500 MG CAPSULE
brand · capsule
$5.82619 per EA filed
eff. 2026-09-23
$5.03307 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 3 NDCs’ NADAC prices is $2.69898 per EA filed.

Of the 12 other products in FDA’s Aminosalicylate class priced per EA, 6 have a higher middle NADAC price and 6 a lower one. The one in the middle is MESALAMINE 1,000 MG SUPP, at $1.28382 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $60.30 for 30 capsules, at an average of $2.00989 per EA in 2024 (2024-01-01 to 2024-12-31) for “Mesalamine Dr” and “Mesalamine”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 47,962 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for MESALAMINE DR 400 MG CAPSULE labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Mesalamine Dr / Mesalamine: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.